Is Immediate Adjunctive CBT More Beneficial than Delayed CBT in Treating Depression?: A Pilot Study

Journal of Psychiatric Practice

Volumn 21, Issue 2, 2015, Pages 107-113

  Rizvi, Sakina J ^a   Zaretsky, Ari ^a   Schaffer, Ayal ^a   Levitt, Anthony ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cognitive behavioral therapy (CBT); delayed treatment; efficacy; major depression; quality of life

Indexed keywords

AMFEBUTAMONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; LEISURE; MALE; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; REMISSION; SECONDARY ANALYSIS; SOCIAL INTERACTION; THERAPY DELAY; TREATMENT DURATION; DEPRESSIVE DISORDER, MAJOR; MIDDLE AGED; OUTCOME ASSESSMENT; PROCEDURES; TIME;

ADULT; COGNITIVE THERAPY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PILOT PROJECTS; TIME FACTORS;

EID: 84953343941     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pra.0000462603.71983.15     Document Type: Article

References (43)

1. Alonso J, Angermeyer MC, Bernert S, et al. Prevalence of mental disorders in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl. 2004;420:21-27.
2. Stewart WF, Ricci JA, Chee E, et al. Cost of lost productive work time among US workers with depression. JAMA. 2003;289:3135-3144.
3. Aikens JE, Nease DE Jr, Klinkman MS. Explaining patients' beliefs about the necessity and harmfulness of antidepressants. Ann Fam Med. 2008;6:23-29.
4. Demyttenaere K, Adelin A, Patrick M, et al. Six-month compliance with antidepressant medication in the treatment of major depressive disorder. Int Clin Psycho-pharmacol. 2008;23:36-42.
5. Schatzberg AF. Safety and tolerability of antidepressants: Weighing the impact on treatment decisions. J Clin Psychiatry. 2007;68(Suppl 8):26-34.
6. Brent D, Emslie G, Clarke G, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: The TORDIA randomized controlled trial. JAMA. 2008;299:901-913.
7. Feldman G. Cognitive and behavioral therapies for depression: Overview, new directions, and practical recommendations for dissemination. Psychiatr Clin North Am. 2007; 30:39-50.
8. Fu CH, Williams SC, Cleare AJ, et al. Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biol Psychiatry. 2008;64: 505-512.
9. Hofmann SG, Smits JA. Cognitive-behavioral therapy for adult anxiety disorders: A meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry. 2008;5:e1-e12.
10. Shelton RC. Augmentation strategies to increase antide-pressant efficacy. J Clin Psychiatry. 2007; 68(Suppl 10): 18-22.
11. Wilson GT, Fairburn CC, Agras WS, et al. Cognitive-behavioral therapy for bulimia nervosa: Time course and mechanisms of change. J Consult Clin Psychol. 2002;70: 267-274.
12. DeRubeis RJ, Hollon SD, Amsterdam JD, et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry. 2005;62:409-416.
13. Kennedy SH, Konarski JZ, Segal ZV, et al. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am J Psychiatry. 2007;164:778-788.
14. Kratochvil C, Emslie G, Silva S, et al. Acute time to response in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry. 2006;45:1412-1418.
15. Wilkinson PO, Goodyer IM. The effects of cognitive-behavioural therapy on mood-related ruminative response style in depressed adolescents. Child Adolesc Psychiatry Ment Health. 2008;2:3.
16. Cuijpers P, van Straten A, Warmerdam L, et al. Psycho-therapy versus the combination of psychotherapy and pharmacotherapy in the treatment of depression: A meta-analysis. Depress Anxiety. 2009;26:279-288.
17. Dobson KS, Hollon SD, Dimidjian S, et al. Randomized trial of behavioral activation, cognitive therapy, and anti-depressant medication in the prevention of relapse and recurrence in major depression. J Consult Clin Psychol. 2008;76:468-477.
18. Vittengl JR, Clark LA, Dunn TW, et al. Reducing relapse and recurrence in unipolar depression: A comparative meta-analysis of cognitive therapy's effects. J Consult Clin Psychol. 2007;75:475-488.
19. Parikh SV, Segal ZV, Grigoriadis S, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication. J Affect Disord. 2009; 117(Suppl 1):S15-S25.
20. Mojtabai R, Olofson M. National trends in psychotherapy by office-based psychiatrists. Arch Gen Psychiatry. 2008; 65:962-970.
21. Somers J, Queree M. Cognitive Behavioural Therapy. British Columbia Ministry of Health. 2006:1-148.
22. Wilkinson E. Access to psychological therapies almost non-existent. Lancet. 2007;370:121-122.
23. Leszcz M, MacKenzie R, el-Guebaly N, et al. Part V: Canadian psychiatrists' use of psychotherapy. Canadian Psychiatric Association Bulletin. 2002 (available at https://ww1.cpa-apc.org/Publications/Archives/Bulletin/2002/october/prn2001part5.asp, accessed January 20, 2015).
24. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician Version (SCID-CV). Washington, DC: American Psychiatric Press; 1997.
25. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
26. Greenberger D, Padesky CA. Mind Over Mood: Change How You Feel by Changing the Way You Think. New York: Guilford Press; 1995.
27. Beck AT, Steer RA, Ball R, et al. Comparison of Beck Depression Inventories-IA and-II in psychiatric outpatients. J Pers Assess. 1996;67:588-597.
28. Altshuler L, Mintz J, Leight K. The Life Functioning Questionnaire (LFQ): A brief, gender-neutral scale assessing functional outcome. Psychiatry Res. 2002;112:161-182.
29. Gloaguen V, Cottraux J, Cucherat M, et al. A meta-analy-sis of the effects of cognitive therapy in depressed patients. J Affect Disord. 1998;49:59-72.
30. Thase ME, Friedman ES, Biggs MM, et al. Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: A STAR∗D report. Am J Psychiatry. 2007;164:739-752.
31. Scott J, Eccleston D, Boys R. Can we predict the persistence of depression? Br J Psychiatry. 1992;161:633-637.
32. Sotsky SM, Glass DR, Shea MT, et al. Patient predictors of response to psychotherapy and pharmacotherapy: Findings in the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry. 1991;148:997-1008.
33. Gormley N, O'Leary D, Costello F. First admissions for depression: Is the 'no-treatment interval' a critical predictor of time to remission? J Affect Disord. 1999;54:49-54.
34. Okuda A, Suzuki T, Kishi T, et al. Duration of untreated illness and antidepressant fluvoxamine response in major depressive disorder. Psychiatry Clin Neurosci. 2010;64: 268-273.
35. Hollon SD, DeRubeis RJ, Shelton RC, et al. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry. 2005;62: 417-422.
36. Agosti V, Stewart JW. Social functioning and residual symptomatology among outpatients who responded to treatment and recovered from major depression. J Affect Disord. 1998;47:207-210.
37. Greer TL, Kurian BT, Trivedi MH. Defining and measuring functional recovery from depression. CNS Drugs. 2010;24:267-284.
38. Molenaar PJ, Dekker J, Van R, et al. Does adding psychotherapy to pharmacotherapy improve social functioning in the treatment of outpatient depression? Depress Anxiety. 2007;24:553-562.
39. Scott J, Teasdale JD, Paykel ES, et al. Effects of cognitive therapy on psychological symptoms and social functioning in residual depression. Br J Psychiatry. 2000;177:440-446.
40. Vittengl JR, Clark LA, Jarrett RB. Improvement in social-interpersonal functioning after cognitive therapy for recurrent depression. Psychol Med. 2004;34:643-658.
41. Bockting CL, Spinhoven P, Wouters LF, et al. Long-term effects of preventive cognitive therapy in recurrent depression: A 5.5-year follow-up study. J Clin Psychiatry. 2009;70:1621-1628.
42. Kennard BD, Emslie GJ, Mayes TL, et al. Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder. J Am Acad Child Adolesc Psychiatry. 2008;47:1395-1404.
43. Petersen T, Harley R, Papakostas GI, et al. Continuation cognitive-behavioural therapy maintains attributional style improvement in depressed patients responding acutely to fluoxetine. Psychol Med. 2004;34:555-561.